Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27,615,000
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
6,157,008
-
Shares change
-
-11,034
-
Total reported value, excl. options
-
$2,094,000
-
Value change
-
-$3,300
-
Number of buys
-
6
-
Number of sells
-
-2
-
Price
-
$0.3404
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q3 2022
14 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q3 2022.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,157,008 shares
of 27,615,000 outstanding shares and own 22.3% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,813,489 shares), JOHNSON & JOHNSON (2,133,402 shares), MMCAP International Inc. SPC (684,451 shares), ROYCE & ASSOCIATES LP (158,655 shares), MILLENNIUM MANAGEMENT LLC (87,757 shares), Virtu Financial LLC (68,813 shares), JANE STREET GROUP, LLC (59,768 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (58,700 shares), CITADEL ADVISORS LLC (31,945 shares), and RENAISSANCE TECHNOLOGIES LLC (30,300 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.